HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT
Harmony Biosciences (Nasdaq: HRMY) has announced its participation in the Oppenheimer Movers in Rare Disease Summit in New York. The company's management team will engage in a fireside chat scheduled for Thursday, December 12, 2024, at 9:00 a.m. ET. Interested parties can access a webcast of the discussion through the investor relations section of Harmony's website.
Harmony Biosciences (Nasdaq: HRMY) ha annunciato la sua partecipazione al Oppenheimer Movers in Rare Disease Summit a New York. Il team dirigenziale dell'azienda parteciperà a una chiacchierata informale programmata per giovedì 12 dicembre 2024, alle 9:00 ET. Le parti interessate possono accedere a un webcast della discussione attraverso la sezione relazioni con gli investitori del sito web di Harmony.
Harmony Biosciences (Nasdaq: HRMY) ha anunciado su participación en el Oppenheimer Movers in Rare Disease Summit en Nueva York. El equipo de gestión de la compañía participará en una charla informal programada para el jueves 12 de diciembre de 2024, a las 9:00 a.m. ET. Las partes interesadas pueden acceder a un webcast de la discusión a través de la sección de relaciones con los inversores en el sitio web de Harmony.
하모니 바이오사이언스 (Nasdaq: HRMY)는 뉴욕에서 열리는 오펜하이머 희귀질환 서밋에 참가한다고 발표했습니다. 회사의 경영진 팀은 2024년 12월 12일 목요일 오전 9시 ET에 예정된 화기애애한 대화에 참여할 예정입니다. 관심 있는 분들은 하모니 웹사이트의 투자자 관계 섹션을 통해 논의의 웹캐스트에 접근할 수 있습니다.
Harmony Biosciences (Nasdaq: HRMY) a annoncé sa participation au Oppenheimer Movers in Rare Disease Summit à New York. L'équipe de direction de l'entreprise participera à une discussion informelle prévue pour le jeudi 12 décembre 2024, à 9h00 ET. Les parties intéressées peuvent accéder à un webinaire de la discussion via la section relations investisseurs du site Web de Harmony.
Harmony Biosciences (Nasdaq: HRMY) hat seine Teilnahme am Oppenheimer Movers in Rare Disease Summit in New York bekannt gegeben. Das Management-Team des Unternehmens wird an einem Fachgespräch teilnehmen, das für Donnerstag, den 12. Dezember 2024, um 9:00 Uhr ET geplant ist. Interessierte können über den Bereich Investorenbeziehungen auf der Website von Harmony auf das Webcast der Diskussion zugreifen.
- None.
- None.
A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-oppenheimer-movers-in-rare-disease-summit-302320185.html
SOURCE Harmony Biosciences
FAQ
When is Harmony Biosciences (HRMY) presenting at the Oppenheimer Rare Disease Summit 2024?
How can investors watch Harmony Biosciences' (HRMY) Oppenheimer Summit presentation?
What type of presentation will Harmony Biosciences (HRMY) give at the Oppenheimer Summit?
Where is the Oppenheimer Rare Disease Summit 2024 with Harmony Biosciences (HRMY) being held?
